Partnership to develop CDx for cancer in China

05:47 EST 8 Nov 2019 | SmartBrief

Lucence Diagnostics has entered an agreement with China's MEDx Translational Medicine to develop companion diagnostic cancer  -More

Original Article: Partnership to develop CDx for cancer in China


More From BioPortfolio on "Partnership to develop CDx for cancer in China"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...